3EW-22497-17014 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-02-23
Dose 1 — Moderna
2021-03-23
Dose 2 — Moderna
2021-04-30
Registered in v-safe
2021-04-30
Survey response — day 35, dose 2
MedDRA: Diplopia, Emergency care, Nystagmus, Oscillopsia, Visual impairment — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visit

Free text: Symptoms: This is my first check in, but in April 1st I had significant problems with my vision including double vision, oscillopsia, and nystagmus that lasted severely for one week snd then gradually improved. · Healthcare visit (other): After ER, I have been seeing an neuro-opthalmoloogist

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-04-30
Report sent to call center — day 35, dose 2
Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional

1 call case(s)
2021-05-05
Health check-in — day 42, dose 2
Feeling: Good

Adult check-in
2021-06-22
Health check-in — 3 months, dose 2
Feeling: Good

Adult check-in
2022-02-10
Call successful
Reported to VAERS voluntarily prior to GDIT contact
2022-03-23
Survey response — 12 months, dose 2
MedDRA: Reaction to previous exposure to any vaccine, Taste disorder, Visual impairment — Feeling: Good

Free text: 8 days after my booster, my sense of taste was altered and it stayed that way for 3 to 4 weeks. The timing was the same as the onset of vision problems 8 days after my 2nd shot.

MedDRA releases: 2024-11 · check-in free text available

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-02-23	Moderna
2	2021-03-23	Moderna

Call center

1 call center case

1 successful

VAERS report filed, before or during a call: 1

See the call center timeline

Free text

Release 8 — day 35, dose 2

2021-04-30

Symptoms: This is my first check in, but in April 1st I had significant problems with my vision including double vision, oscillopsia, and nystagmus that lasted severely for one week snd then gradually improved.

Healthcare visit (other): After ER, I have been seeing an neuro-opthalmoloogist

Release 11 — 12 months, dose 2

2022-03-23

Symptoms: 8 days after my booster, my sense of taste was altered and it stayed that way for 3 to 4 weeks. The timing was the same as the onset of vision problems 8 days after my 2nd shot.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
HCVO	Emergency care	✓	✓	✓
SD	Diplopia	✓	✓	✓
SD	Nystagmus	✓	✓	✓
SD	Oscillopsia	✓	✓	✓
SD	Reaction to previous exposure to any vaccine	·	·	✓
SD	Taste disorder	·	·	✓
SD	Visual impairment	✓	✓	✓

✓ active code · ○ coded but marked inactive · blank = not in that release